Lyra Therapeutics, Inc.

NASDAQ:LYRA

0.0982 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -10.979-11.873-48.131-22.452-15.156-15.651-15.618-16.255-14.235-19.547-14.484-7.012-13.617-11.055-11.039-7.802-7.021-6.334-4.54-4.232-4.353-4.163-4.201-3.589
Depreciation & Amortization 0.151-1.970.1450.1360.085-0.068-0.0230.2840.2220.2790.2860.280.2780.350.3030.070.0410.0330.0130.0080.0070.0060.0060.008
Deferred Income Tax 0000-5.18700000-2.6690-13.9220000.8790000000
Stock Based Compensation 1.9391.4911.1242.1621.4821.4411.3541.611.7571.7391.1070.8440.7820.7330.6560.5990.5920.4680.6190.1340.1030.0490.0440.048
Change In Working Capital -2.196-1.3292.697-1.368-4.3811.22-0.961-0.763-0.7326.6834.621-6.0171.26-0.34213.461-0.4570.522.098-3.570.0730.3250.1141.1470.528
Accounts Receivables 00000000505-5000000000000
Change In Inventory 0000000000-50000000000000
Change In Accounts Payables -1.113-2.5922.378-0.56-3.5350.796-0.1063.295-2.2441.472-0.976-0.6631.1830.4240.2910.4520.2040.003-0.2940.432-0.12-0.9240.885-0.046
Other Working Capital -1.0831.2630.319-0.808-0.8460.424-0.855-4.058-3.4884.4225.597-0.3540.077-0.76613.17-0.9090.3162.095-3.276-0.3590.4451.0380.2620.574
Other Non Cash Items -0.267-2.54224.1842.0614.099-1.0560.966-0.7260.8241.1132.6697.06713.9221.0590.9680.287-0.879-0.045-0.2940.432-0.120.1670.885-0.046
Operating Cash Flow -11.352-16.223-19.981-22.455-19.058-14.114-14.282-15.85-12.164-10.846-8.47-11.905-11.297-10.3143.381-7.59-5.868-3.78-7.478-4.017-3.918-3.827-3.004-3.005
Investing Activities:
Investments In Property Plant And Equipment 0.058-0.051-0.196-2.149-0.787-0.144-0.071-0.045-0.028-0.029-0.014-0.093-1.083-0.517-0.625-1.16-1.101-0.589-0.077-0.008-0.08-0.01-0.069-0.052
Acquisitions Net 0000-9.96514.8350.4900000000000000000
Purchases Of Investments 0-12.808-14.616-20.525-49.658-42.835-25.49-4.44-64.842000000000000000
Sales Maturities Of Investments 28.0732150.98830.53148.08628259.80000000000000000
Other Investing Activites 00010.006-1.572-14.835-0.490-64.842000000000000000
Investing Cash Flow 28.1318.14136.1767.857-2.359-14.979-0.5615.315-64.87-0.029-0.014-0.093-1.083-0.517-0.625-1.16-1.101-0.589-0.077-0.008-0.08-0.01-0.069-0.052
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued -0.001-0.0030.0098.81319.2420.00250.0970100.495000.0080.6040.0110.3310.26230.3920030.3920000
Common Stock Repurchased 000000000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities 0-0.023-0.0898.644-0.322-0.41847.1850.004-196.988-0.23696.4870.006-0.004-0.0840.1850.2620.007-0.67558.90729.464-0.198-0.0040.0870
Financing Cash Flow -0.001-0.023-0.0898.64418.92-0.41847.1850.004-96.493-0.23696.4870.006-0.004-0.0840.1850.2620.007-0.67558.90729.464-0.198-0.0040.0870
Other Information:
Effect Of Forex Changes On Cash 0000000096.493000000000000000
Net Change In Cash 16.778-8.10516.106-6.554-2.497-29.51132.342-10.531-77.034-11.11188.003-11.992-12.384-10.9152.941-8.488-6.962-5.04451.35225.439-4.196-3.841-2.986-3.057
Cash At End Of Period 42.5725.79231.90515.79922.35326.24255.75323.41133.942110.976122.08734.08446.07658.4669.37566.43474.92281.88486.92835.57610.13714.33318.17421.16